|
Volumn 87, Issue 2, 2002, Pages 189-195
|
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia
a a a a a a a a a a a |
Author keywords
Autoimmune hemolytic anemia; B cell depletion; Chronic idiopathic thrombocytopenic purpura; Rituximab
|
Indexed keywords
AUTOANTIBODY;
CD20 ANTIGEN;
COLD AGGLUTININ;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
PREDNISONE;
RITUXIMAB;
STEROID;
VINCRISTINE SULFATE;
ADULT;
AGED;
ANTIBODY PRODUCTION;
ANTIBODY TITER;
ARTICLE;
AUTOIMMUNE HEMOLYTIC ANEMIA;
B LYMPHOCYTE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DOSE TIME EFFECT RELATION;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG INFUSION;
DRUG MECHANISM;
DRUG RESPONSE;
DRUG SAFETY;
FEMALE;
FOLLICULAR LYMPHOMA;
FOLLOW UP;
HUMAN;
HUMAN CELL;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
IMMUNOSUPPRESSIVE TREATMENT;
LYMPHOCYTE DEPLETION;
MALE;
QUANTITATIVE ASSAY;
REMISSION;
ADULT;
AGED;
ANEMIA, HEMOLYTIC, AUTOIMMUNE;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
AUTOIMMUNE DISEASES;
B-LYMPHOCYTE SUBSETS;
COMBINED MODALITY THERAPY;
DRUG RESISTANCE;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
IMMUNOSUPPRESSIVE AGENTS;
IMMUNOTHERAPY;
MALE;
MIDDLE AGED;
PREDNISONE;
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;
TREATMENT OUTCOME;
|
EID: 0036174699
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (141)
|
References (20)
|